Robert Spiegel, M.D., FACP
Robert J. Spiegel has served on Edge Therapeutics, Inc. Board of Directors since August of 2013. He has been an Associate Professor at Weill Cornell Medical College since 2012, is an Advisor at Warburg Pincus and serves as Chief Medical Officer of PTC Therapeutics, Inc. Prior to joining Edge, Dr. Spiegel spent more than 25 years at Schering-Plough where he was deeply involved in clinical development, culminating with his position as Chief Medical Officer and Senior Vice President of the Schering-Plough Research Institute.
At Schering-Plough, Dr. Spiegel was involved in the filing of over 30 New Drug Applications and interacted with regulatory authorities in the U.S. and globally, serving on the executive committees overseeing all research projects and drug licensing activities. After joining Schering-Plough in 1983, he held titles of increasing responsibility including Director of Clinical Research, Vice President of Clinical Research, and Senior Vice President of Worldwide Clinical Research until he became Chief Medical Officer in 1998. Dr. Spiegel retired from Schering- Plough in 2009. He has also served on the Board of Directors of a number of companies, including Geron Corporation since May 2010, and Cancer Care, Inc.
Dr. Spiegel holds a B.A. from Yale University and an M.D. from the University of Pennsylvania. Following a residency in internal medicine, he completed a fellowship in medical oncology at the National Cancer Institute and held academic positions at the National Cancer Institute and New York University Cancer Center.